Arcellx, Inc. (ACLX)
72.71
+0.73
(+1.01%)
USD |
NASDAQ |
Dec 11, 16:00
72.71
0.00 (0.00%)
After-Hours: 20:00
Arcellx Cash from Investing (Quarterly): -20.03M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -427.00M |
| Geron Corp. | 13.35M |
| Daré Bioscience, Inc. | -0.1747M |
| Cartesian Therapeutics, Inc. | -- |
| Cabaletta Bio, Inc. | -50.08M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -49.21M |
| Cash from Financing (Quarterly) | 86.10M |
| Free Cash Flow | -201.18M |
| Free Cash Flow Per Share (Quarterly) | -0.8748 |
| Free Cash Flow to Equity (Quarterly) | -48.78M |
| Free Cash Flow to Firm (Quarterly) | -49.50M |
| Free Cash Flow Yield | -4.98% |